Clinical Trial Update: Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases

View source ↗

Summary

This clinical trial update describes molecular genetic screening to identify congenital arrhythmogenic diseases. The conditions involved include Long QT Syndrom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Right Ventricular Dysplasia
• Hypertrophic Cardiomyopathy
• Long Qt Syndrome

Snippet

Sponsor: Heidelberg University | Conditions: Long QT Syndrome, Hypertrophic Cardiomyopathy | Status: UNKNOWN